Company Filing History:
Years Active: 2005-2025
Title: The Innovative Contributions of Robert Woodward
Introduction
Robert Woodward is a prominent inventor based in Pleasanton, CA (US), known for his significant contributions to the field of biotechnology. With a total of 15 patents to his name, Woodward has made remarkable advancements in methods related to allograft monitoring and immunosuppressive therapies.
Latest Patents
Among his latest patents, Woodward has developed methods and systems for monitoring a recipient of an allograft. This innovative method involves sequencing techniques that can be utilized to monitor the recipient's health status. A sample containing nucleic acid molecules is obtained from the recipient, and a variety of nucleic acid molecules are isolated and amplified. These molecules undergo amplification reactions using multiple primers to generate numerous DNA molecules, targeting at least 100 independent polymorphisms. The resulting DNA molecules can then be sequenced, providing valuable insights without the need for genotyping the recipient. Additionally, he has created methods for monitoring immunosuppressive therapies in transplant recipients, focusing on the status of allografts and the adjustment of therapies administered to these patients.
Career Highlights
Throughout his career, Woodward has worked with notable companies such as Xdx, Inc. and Expression Diagnostics, Inc. His work has significantly impacted the field of transplant medicine, enhancing the understanding and management of allograft recipients.
Collaborations
Woodward has collaborated with esteemed colleagues, including Jay Wohlgemuth and Kirk E Fry, contributing to the advancement of innovative solutions in his field.
Conclusion
Robert Woodward's contributions to biotechnology and transplant medicine through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the monitoring and management of transplant recipients, showcasing the importance of innovation in healthcare.